Published in PLoS Comput Biol on June 12, 2009
Thymus Transplantation Safety-Efficacy | NCT01220531
Expanded Access Protocol Thymus Transplantation | NCT02274662
The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis. Front Immunol (2013) 1.22
Signaling thresholds govern heterogeneity in IL-7-receptor-mediated responses of naïve CD8(+) T cells. Immunol Cell Biol (2011) 1.14
Thymus involution and regeneration: two sides of the same coin? Nat Rev Immunol (2013) 0.99
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
Quantification of total T-cell receptor diversity by flow cytometry and spectratyping. BMC Immunol (2013) 0.88
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. PLoS One (2012) 0.79
How many TCR clonotypes does a body maintain? J Theor Biol (2015) 0.77
Modeling rejection immunity. Theor Biol Med Model (2012) 0.75
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10
Maintaining the norm: T-cell homeostasis. Nat Rev Immunol (2002) 5.63
Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med (2002) 5.09
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med (1997) 3.53
The spectrum of the DiGeorge syndrome. J Pediatr (1979) 3.24
Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A (1999) 3.06
Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med (1997) 2.95
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78
VDJ recombination. Immunol Today (1992) 2.74
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol (2001) 2.52
Structural basis of T cell recognition. Annu Rev Immunol (1999) 2.45
Homeostasis of alpha beta TCR+ T cells. Nat Immunol (2000) 2.29
Lymphocyte homeostasis. Semin Immunol (1997) 2.15
Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med (1997) 2.15
CD4+ T cell division in irradiated mice requires peptides distinct from those responsible for thymic selection. J Exp Med (1999) 2.04
IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol (1998) 1.85
Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol (1996) 1.76
Lymphocide: cytokines and the control of lymphoid homeostasis. Nat Rev Immunol (2002) 1.70
Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. J Immunol (2003) 1.55
Number and distribution of lymphocytes in man. A critical analysis. Klin Wochenschr (1974) 1.53
T cell homeostasis in tolerance and immunity. J Leukoc Biol (2005) 1.50
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood (2007) 1.49
Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci U S A (1996) 1.44
A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci U S A (1999) 1.37
Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci U S A (2000) 1.34
T cell repertoires and competitive exclusion. J Theor Biol (1994) 1.32
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Homeostatic expansion versus antigen-driven proliferation: common ends by different means? Microbes Infect (2002) 1.27
Homeostasis and T cell regulation. Curr Opin Immunol (2004) 1.26
Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood (2004) 1.26
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood (2003) 1.24
Sensitivity analysis of a nonlinear lumped parameter model of HIV infection dynamics. Bull Math Biol (2004) 1.23
A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood (2000) 1.14
A parameter sensitivity methodology in the context of HIV delay equation models. J Math Biol (2004) 1.13
Peripheral expression of Jak3 is required to maintain T lymphocyte function. J Exp Med (1997) 1.11
Statistical analysis of antigen receptor spectratype data. Bioinformatics (2005) 1.09
Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory. Proc Natl Acad Sci U S A (1998) 1.06
Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool. Immunology (1999) 1.02
The role of cellular competition in B cell survival and selection of B cell repertoires. Eur J Immunol (1995) 1.02
Homeostasis of T cell diversity. Cell Mol Immunol (2005) 1.02
T cell homeostasis in steady state and lymphopenic conditions. Immunol Lett (2006) 0.99
The concept of space and competition in immune regulation. Immunology (2004) 0.95
Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest (1997) 0.95
Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl (1987) 0.93
Factors affecting success of thymus transplantation for complete DiGeorge anomaly. Am J Transplant (2008) 0.92
Use of allograft biopsies to assess thymopoiesis after thymus transplantation. J Immunol (2008) 0.89
Competitive control of the self-renewing T cell repertoire. Int Immunol (1997) 0.89
Ecological and evolutionary principles in immunology. Ecol Lett (2006) 0.86
Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. Proc Natl Acad Sci U S A (1999) 0.86
Resource competition determines selection of B cell repertoires. J Theor Biol (2001) 0.84
Biological half-life of normal and truncated human IgG3 in scid mice. Eur J Immunol (1991) 0.80
Epitope down-modulation as a mechanism for the coexistence of competing T-cells. J Theor Biol (2004) 0.80
The human thymic microenvironment during organ culture. Clin Immunol Immunopathol (1997) 0.76
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity (2013) 4.82
Advantage of rare HLA supertype in HIV disease progression. Nat Med (2003) 4.08
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol (2011) 4.06
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol (2012) 3.69
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
Identifying differential expression in multiple SAGE libraries: an overdispersed log-linear model approach. BMC Bioinformatics (2005) 3.12
Statistical mixture modeling for cell subtype identification in flow cytometry. Cytometry A (2008) 3.06
Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics (2005) 2.78
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods (2009) 2.75
SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics (2005) 2.41
Diversification of Ig superfamily genes in an invertebrate. Science (2004) 2.25
The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol (2010) 2.20
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One (2011) 2.02
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One (2011) 1.99
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med (2011) 1.97
Microbial colonization influences early B-lineage development in the gut lamina propria. Nature (2013) 1.96
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. J Virol (2012) 1.86
Invertebrate immune systems--not homogeneous, not simple, not well understood. Immunol Rev (2004) 1.72
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog (2011) 1.70
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A (2012) 1.70
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68
Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence Histology. Bayesian Anal (2009) 1.58
SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements. Bioinformatics (2010) 1.57
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood (2007) 1.49
Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol (2004) 1.39
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation. J Virol (2011) 1.32
Identification and utilization of arbitrary correlations in models of recombination signal sequences. Genome Biol (2002) 1.29
Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cells. Toxicol Pathol (2002) 1.27
Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood (2004) 1.26
Measurement of cell migration on surface-bound fibronectin gradients. Langmuir (2004) 1.21
First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One (2010) 1.20
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. J Clin Invest (2014) 1.19
Flow: Statistics, visualization and informatics for flow cytometry. Source Code Biol Med (2008) 1.17
A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface (2010) 1.13
Statistical analysis of antigen receptor spectratype data. Bioinformatics (2005) 1.09
Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. J Immunol (2010) 1.07
Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling. J Exp Med (2003) 1.06
Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg (2004) 1.06
Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants. Proc Natl Acad Sci U S A (2010) 1.06
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol (2004) 1.05
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. Proc Natl Acad Sci U S A (2013) 1.05
Thymus transplantation. Clin Immunol (2010) 1.04
Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. Vaccine (2008) 1.03
Corticosteroids regulate epithelial cell differentiation and Hassall body formation in the human thymus. J Immunol (2004) 1.01
Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res (2008) 1.00
Patient socioeconomic status is an independent predictor of operative mortality. Ann Surg (2010) 0.98
Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cell Immunol (2010) 0.95
First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood (2010) 0.94
The Multiscale Systems Immunology project: software for cell-based immunological simulation. Source Code Biol Med (2008) 0.93
beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J Immunol (2009) 0.93
Thymus transplantation in complete DiGeorge anomaly. Immunol Res (2009) 0.92
Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol (2006) 0.92
SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization. Bioinformatics (2005) 0.91
Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2006) 0.90
Use of allograft biopsies to assess thymopoiesis after thymus transplantation. J Immunol (2008) 0.89
Quantification of total T-cell receptor diversity by flow cytometry and spectratyping. BMC Immunol (2013) 0.88
Amino acid biophysical properties in the statistical prediction of peptide-MHC class I binding. Immunome Res (2007) 0.88
Comèl-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol (2009) 0.88
Human FOXN1-deficiency is associated with αβ double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation. PLoS One (2012) 0.87
Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage. Proteins (2015) 0.86
Thymic microenvironment reconstitution after postnatal human thymus transplantation. Clin Immunol (2011) 0.86
A Bayesian approach for estimating calibration curves and unknown concentrations in immunoassays. Bioinformatics (2010) 0.84
Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection. Semin Immunol (2007) 0.84
Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. Int Immunol (2006) 0.83
Treatment of infants with complete DiGeorge anomaly. J Allergy Clin Immunol (2008) 0.83
Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency. J Clin Immunol (2012) 0.83
Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly. J Allergy Clin Immunol (2011) 0.81
Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly. Clin Immunol (2007) 0.81
Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II. Eur J Immunol (2008) 0.80
Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation. J Allergy Clin Immunol (2010) 0.79
A model for migratory B cell oscillations from receptor down-regulation induced by external chemokine fields. Bull Math Biol (2013) 0.79
Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers. J Allergy Clin Immunol (2011) 0.78
Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection. J Theor Biol (2011) 0.78
Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates. Immunogenetics (2003) 0.78
An information-theoretic method for the treatment of plural ancestry in phylogenetics. Mol Biol Evol (2008) 0.77
Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes. Immunol Res (2009) 0.77
Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. J Clin Immunol (2015) 0.77
Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains. Immunome Res (2009) 0.76
Improving peptide-MHC class I binding prediction for unbalanced datasets. BMC Bioinformatics (2008) 0.76
Clinical course and outcome predictors of critically ill infants with complete DiGeorge anomaly following thymus transplantation. Pediatr Crit Care Med (2014) 0.75
Mixtures of Gaussian Wells: Theory, Computation, and Application. Comput Stat Data Anal (2012) 0.75
Computational immunology--from bench to virtual reality. Ann Acad Med Singapore (2007) 0.75
Successful extracorporeal membrane oxygenation for respiratory failure in an infant with DiGeorge anomaly, following thymus transplantation. Respir Care (2011) 0.75